Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.
about
Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@ast
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@en
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@nl
type
label
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@ast
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@en
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@nl
prefLabel
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@ast
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@en
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Long-term oncological outcomes ...... ed, high-risk prostate cancer.
@en
P2093
Aaron Bernie
Alexandra C Maschino
Badrinath R Konety
Daniel D Sjoberg
James A Eastham
Jonathan L Silberstein
Stephen A Poon
W Kevin Kelly
P2860
P356
10.1111/BJU.12676
P577
2015-04-17T00:00:00Z